Intuitive Surgical (NASDAQ:ISRG) Stock Rating Lowered by Deutsche Bank Aktiengesellschaft

Intuitive Surgical (NASDAQ:ISRG) was downgraded by stock analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “sell” rating in a report issued on Monday, Marketbeat reports. They currently have a $440.00 target price on the medical equipment provider’s stock. Deutsche Bank Aktiengesellschaft’s price target indicates a potential downside of 21.02% from the company’s previous close.

Several other research firms have also commented on ISRG. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a “buy” rating in a report on Monday, April 14th. Evercore ISI cut their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a report on Wednesday, April 23rd. Citigroup reaffirmed a “buy” rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. Finally, Barclays dropped their price target on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $588.95.

Intuitive Surgical Stock Down 0.2%

NASDAQ:ISRG opened at $557.08 on Monday. Intuitive Surgical has a 52 week low of $413.52 and a 52 week high of $616.00. The company has a fifty day simple moving average of $521.99 and a two-hundred day simple moving average of $539.16. The company has a market cap of $199.67 billion, a price-to-earnings ratio of 86.91, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter last year, the business posted $1.50 EPS. On average, analysts expect that Intuitive Surgical will post 6.43 EPS for the current year.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. The trade was a 60.72% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 25,443 shares of company stock worth $12,692,195. Corporate insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Sycomore Asset Management boosted its holdings in shares of Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Castleark Management LLC grew its holdings in Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock valued at $47,221,000 after buying an additional 2,990 shares during the period. Truist Financial Corp lifted its holdings in shares of Intuitive Surgical by 3.0% during the 4th quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider’s stock worth $129,494,000 after acquiring an additional 7,298 shares during the period. FourThought Financial Partners LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $1,158,000. Finally, Longbow Finance SA acquired a new position in Intuitive Surgical during the fourth quarter worth approximately $4,431,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.